CN112834752B - Blood glucose standardized measurement system, method, terminal and medium suitable for large-scale crowd - Google Patents
Blood glucose standardized measurement system, method, terminal and medium suitable for large-scale crowd Download PDFInfo
- Publication number
- CN112834752B CN112834752B CN202110013925.XA CN202110013925A CN112834752B CN 112834752 B CN112834752 B CN 112834752B CN 202110013925 A CN202110013925 A CN 202110013925A CN 112834752 B CN112834752 B CN 112834752B
- Authority
- CN
- China
- Prior art keywords
- blood glucose
- blood
- batch
- data
- quality control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000008280 blood Substances 0.000 title claims abstract description 229
- 210000004369 blood Anatomy 0.000 title claims abstract description 229
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 178
- 239000008103 glucose Substances 0.000 title claims abstract description 178
- 238000005259 measurement Methods 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims description 17
- 230000002159 abnormal effect Effects 0.000 claims abstract description 52
- 238000003908 quality control method Methods 0.000 claims abstract description 48
- 238000001514 detection method Methods 0.000 claims abstract description 33
- 238000000691 measurement method Methods 0.000 claims abstract description 10
- 238000012360 testing method Methods 0.000 claims description 43
- 230000005856 abnormality Effects 0.000 claims description 11
- 238000004590 computer program Methods 0.000 claims description 10
- 238000013480 data collection Methods 0.000 claims description 2
- 238000007689 inspection Methods 0.000 abstract description 9
- 238000012545 processing Methods 0.000 description 14
- 230000006870 function Effects 0.000 description 7
- 238000004891 communication Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000012937 correction Methods 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000802 evaporation-induced self-assembly Methods 0.000 description 1
- 238000011425 standardization method Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The application provides a blood glucose standardized measurement system, a blood glucose standardized measurement method, a blood glucose standardized measurement terminal and a blood glucose standardized measurement medium suitable for a large number of people, which comprise a startup quality control module, wherein the startup quality control module is used for performing quality control after startup; the blood sugar data acquisition module is used for acquiring blood sugar data of a batch of people after the startup quality control module finishes startup quality control; and the reverse checking module is used for reversely checking whether the blood sugar data acquisition module works normally according to the abnormal rate of blood sugar data of the batch crowd. The application carries out startup quality control before formally carrying out mass measurement, thereby greatly improving the detection quality and realizing the standardization and the precision of blood glucose measurement. In addition, the reverse inspection of the measuring instrument is performed on the basis of the crowd detection data in batches, which is an inspection function which cannot be realized by a small amount of data, and the detection quality is reversely improved.
Description
Technical Field
The application relates to the technical field of standardized measurement, in particular to a blood glucose standardized measurement system, a blood glucose standardized measurement method, a blood glucose standardized measurement terminal and a blood glucose standardized measurement medium suitable for a large number of people.
Background
Today, blood glucose measurement is becoming more and more convenient, with home blood glucose meters that facilitate the patient's use at home, and with medical blood glucose meters that allow the patient to go to the hospital for blood glucose measurement. However, whether the blood glucose meter is used for household or medical use, if the standard quality control and measurement are not carried out according to the requirements, the measurement results are easy to deviate, the related quality control and measurement results cannot be directly stored and uploaded, and the time and the labor are wasted due to the need of manual filling; and moreover, the deviation degree of the blood glucose measurement data of the large-scale crowd cannot be systematically analyzed, so that the accuracy of the blood glucose measurement data of the crowd is reversely traced, and whether a measuring instrument, consumable materials and a measuring process have problems or not is timely perceived.
Disclosure of Invention
In view of the above-mentioned drawbacks of the prior art, it is an object of the present application to provide a standardized blood glucose measuring system, method, terminal and medium suitable for large groups of people, for solving the problems of the prior art.
To achieve the above and other related objects, a first aspect of the present application provides a blood glucose standardization measuring system suitable for a large population, comprising: the starting-up quality control module is used for controlling the quality after starting up; the blood sugar data acquisition module is used for acquiring blood sugar data of a batch of people after the startup quality control module finishes startup quality control; and the reverse checking module is used for reversely checking whether the blood sugar detector, the blood sugar test paper and the blood sugar measuring staff work normally or not according to the abnormal rate of blood sugar data of the batch crowd.
In some embodiments of the first aspect of the present application, the power-on quality control module performs blood glucose detection on a standard sample after power-on; if the blood glucose detection value of the standard sample accords with the theoretical value, determining that the blood glucose data acquisition module accords with the quality control requirement; and if the blood sugar detection value does not accord with the theoretical value, debugging the blood sugar data acquisition module until the blood sugar detection value of the standard sample accords with the theoretical value.
In some embodiments of the first aspect of the present application, the reverse checking module performs a reverse check according to the deviation of the blood glucose data of the population, and the reverse check term includes at least checking whether the blood glucose values are distributed in a biased state.
In some embodiments of the first aspect of the present application, the reverse checking module checks whether the blood glucose meter, blood glucose test paper and blood glucose measuring person are operating properly comprises: comparing the abnormal rates of blood glucose data of the batch of people under the conditions of the same operator, the same measuring equipment and test paper of different batches, and judging that the test paper is abnormal if the abnormal rates are higher than a preset threshold value; comparing the abnormal rates of blood glucose data of the batch of people under the conditions of the same operator, the same batch of paper strips and different measuring equipment, and judging that the measuring equipment is abnormal if the abnormal rates are higher than a preset threshold value; comparing abnormal rates of blood glucose data of the batch of people under the conditions of the same batch of paper strips, the same measuring equipment and different operators, and judging that the blood glucose measuring personnel operate abnormally if the abnormal rates are higher than a preset threshold value; comparing the abnormal rates of the blood glucose data of the batch population under the conditions of different equipment models, and judging that the equipment of the model is abnormal if the abnormal rates are higher than a preset threshold value.
In some embodiments of the first aspect of the present application, the start-up quality control module is configured to determine whether the use and the storage of the blood glucose test paper meet the requirements according to the in-out database data of the blood glucose test paper, so as to determine whether the blood glucose test paper works normally.
To achieve the above and other related objects, a second aspect of the present application provides a blood glucose standardization measuring method suitable for a large population, comprising: performing quality control after starting up; collecting blood sugar data of a batch of people after the startup quality control is completed; according to the abnormal rate of blood sugar data of the batch crowd, reversely checking whether the blood sugar detector, the blood sugar test paper and blood sugar measuring staff operate normally or not.
In some embodiments of the second aspect of the present application, the performing quality control after power-on includes: after starting up, detecting blood sugar of a standard sample; if the blood glucose detection value of the standard sample accords with the theoretical value, determining that the blood glucose data acquisition module accords with the quality control requirement; and if the blood sugar detection value does not accord with the theoretical value, debugging the blood sugar data acquisition module until the blood sugar detection value of the standard sample accords with the theoretical value.
In some embodiments of the second aspect of the present application, the reversely checking whether the blood glucose meter, the blood glucose test paper and the blood glucose measuring person operate normally according to the abnormal rate of the blood glucose data of the lot group includes: and reversely checking whether the blood glucose detector, the blood glucose test paper and blood glucose measuring staff operate normally or not according to the deviation degree of blood glucose data of the batch population.
To achieve the above and other related objects, a third aspect of the present application provides a computer-readable storage medium having stored thereon a computer program which, when executed by a processor, implements the blood glucose standardization measuring method suitable for a large population.
To achieve the above and other related objects, a fourth aspect of the present application provides an electronic terminal, comprising: a processor and a memory; the memory is used for storing a computer program, and the processor is used for executing the computer program stored in the memory, so that the terminal executes the blood glucose standardized measurement method suitable for a large number of people.
As described above, the blood glucose standardized measurement system, method, terminal and medium suitable for large-scale crowd of the application have the following beneficial effects: the application carries out startup quality control before formally carrying out mass measurement, thereby greatly improving the detection quality and realizing the standardization and the precision of blood glucose measurement. In addition, the reverse inspection of the measuring instrument is performed on the basis of the crowd detection data in batches, which is an inspection function which cannot be realized by a small amount of data, and the detection quality is reversely improved.
Drawings
Fig. 1 is a schematic diagram of a standardized blood glucose measurement system suitable for a large population in accordance with an embodiment of the present application.
Fig. 2 is a flow chart of a standardized blood glucose measurement method suitable for a large population in accordance with an embodiment of the present application.
Fig. 3 is a schematic structural diagram of an electronic terminal according to an embodiment of the application.
Detailed Description
Other advantages and effects of the present application will become apparent to those skilled in the art from the following disclosure, which describes the embodiments of the present application with reference to specific examples. The application may be practiced or carried out in other embodiments that depart from the specific details, and the details of the present description may be modified or varied from the spirit and scope of the present application. It should be noted that the following embodiments and features in the embodiments may be combined with each other without conflict.
In the following description, reference is made to the accompanying drawings, which illustrate several embodiments of the application. It is to be understood that other embodiments may be utilized and that mechanical, structural, electrical, and operational changes may be made without departing from the spirit and scope of the present application. The following detailed description is not to be taken in a limiting sense, and the scope of embodiments of the present application is defined only by the claims of the issued patent. The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the application. Spatially relative terms, such as "upper," "lower," "left," "right," "lower," "upper," and the like, may be used herein to facilitate a description of one element or feature as illustrated in the figures as being related to another element or feature.
In the present application, unless explicitly specified and limited otherwise, the terms "mounted," "connected," "secured," "held," and the like are to be construed broadly, and may be, for example, fixedly connected, detachably connected, or integrally connected; can be mechanically or electrically connected; can be directly connected or indirectly connected through an intermediate medium, and can be communication between two elements. The specific meaning of the above terms in the present application can be understood by those of ordinary skill in the art according to the specific circumstances.
Furthermore, as used herein, the singular forms "a", "an" and "the" are intended to include the plural forms as well, unless the context indicates otherwise. It will be further understood that the terms "comprises," "comprising," "includes," and/or "including" specify the presence of stated features, operations, elements, components, items, categories, and/or groups, but do not preclude the presence, presence or addition of one or more other features, operations, elements, components, items, categories, and/or groups. The terms "or" and/or "as used herein are to be construed as inclusive, or meaning any one or any combination. Thus, "A, B or C" or "A, B and/or C" means "any of the following: a, A is as follows; b, a step of preparing a composite material; c, performing operation; a and B; a and C; b and C; A. b and C). An exception to this definition will occur only when a combination of elements, functions or operations are in some way inherently mutually exclusive.
In order to make the objects, technical solutions and advantages of the present invention more apparent, further detailed description of the technical solutions in the embodiments of the present invention will be given by the following examples with reference to the accompanying drawings. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the invention.
Referring to fig. 1, a schematic structure of a standardized blood glucose measuring system suitable for a large population in accordance with an embodiment of the present invention is shown. The blood glucose standardization measurement system 100 provided in this embodiment includes a power-on quality control module 101, a blood glucose data acquisition module 102, and a reverse inspection module 103.
Specifically, the power-on quality control module 101 is configured to perform quality control after power-on; the blood glucose data acquisition module 102 is used for acquiring blood glucose data of a batch of people after the startup quality control module completes startup quality control; the reverse checking module 103 is used for checking whether the blood sugar data acquisition module works normally or not according to the abnormal rate of blood sugar data of the batch crowd.
In some examples, the manner in which the power-on quality control module 101 performs quality control includes: the power-on quality control module 101 performs blood glucose detection on a standard sample after power-on; if the blood glucose detection value of the standard sample accords with the theoretical value, determining that the blood glucose data acquisition module accords with the quality control requirement; and if the blood sugar detection value does not accord with the theoretical value, debugging the blood sugar data acquisition module until the blood sugar detection value of the standard sample accords with the theoretical value.
It should be noted that, in the existing blood glucose meter, whether it is for home use or for medical use, measurement is usually started after the blood glucose meter is turned on, but there is a problem in that the blood glucose meter is likely to be not used accurately again after being turned off. In addition, common household blood glucose meters or medical blood glucose meters are used for measuring by a single person or have fewer measurement times in a period of time even though the blood glucose meters are used for measuring by a plurality of persons; however, the standardized blood glucose measurement system of the present invention is specific to a large population (e.g., community service institutions dedicated to chronic disease detection), which places higher demands on the accuracy of the blood glucose meter measurement, otherwise, once there is an error, it is likely that the massive data will be discarded. In view of the above, the present invention provides a solution for quality control of a stand horse after starting up, and a blood glucose meter tests a standard sample after starting up; if the test result is consistent with the theoretical result (for example, the result values are all 9), the blood sugar data acquisition module is considered to be in accordance with the quality control requirement, otherwise, the blood sugar data acquisition module is considered to be continuously debugged until the blood sugar detection value of the standard sample is consistent with the theoretical value.
In some examples, the blood glucose data collection module 102 may be a blood glucose meter or other device capable of performing blood glucose measurements, and may be a photoelectric type or electrode type. Because the blood glucose data acquisition module 102 in this embodiment needs to perform blood glucose test for a large number of people, the blood glucose data of the large number of people should be performed after the startup quality control is completed.
In some examples, the reverse checking module 103 is used for reversely checking whether the blood glucose detector, the blood glucose test paper and the blood glucose measuring staff work normally or not on the basis of collecting blood glucose data of a large number of people. Specifically, the blood glucose standardized measurement suitable for large-batch crowds can collect batch blood glucose data in a short time, and the data can be used for analyzing abnormal rates of operation of a blood glucose detector, blood glucose test paper and blood glucose measuring staff.
Further, the reverse checking module 103 performs reverse checking according to the deviation degree of the blood glucose data of the crowd, and the reverse checking item at least includes checking whether the blood glucose values are in a biased distribution. The off-set distribution refers to the distribution that the peak of the frequency distribution is located at one side and the tail extends to the other side, and can be divided into positive off-set and negative off-set. For example, the degree of deviation may be expressed by a deviation factor, which is expressed by the formula:
Wherein,
Wherein g1 represents a bias number; x is the variable value of the variable, and the variable value is the same as the variable value,For the sample mean, n is the frequency,/>For merging the correction numbers, if the group distance is used in the calculation process, the correction is needed, and if the original data is used for direct calculation, the correction is not needed; if g1 is 0, symmetry is indicated; g1 is positive, the curve is in a positive bias state, and the tail part with a longer curve is on the right side; when g1 is negative, the curve is in a negative bias state, and the tail part with a longer curve is at the left side; the larger the absolute value of g1, the more the deviation is indicated.
In some examples, to further distinguish whether a glucose meter is abnormal, a blood glucose test strip is abnormal, or an operator is operating abnormal, the present example provides the following solutions:
1) Comparing abnormal rates of blood glucose data of batch groups under the conditions of the same operator, the same measuring equipment and test papers of different batches; if the abnormality rate is higher than the preset threshold value, judging that the blood glucose test paper is abnormal.
2) Comparing abnormal rates of blood glucose data of batches of people under the conditions of the same operator, the same batch of paper strips and different measuring equipment; if the abnormality rate is higher than a preset threshold value, judging that the measuring equipment is abnormal.
3) Comparing abnormal rates of blood glucose data of the batch of people under the conditions of the same batch of paper strips, the same measuring equipment and different operators; if the abnormality rate is higher than the preset threshold value, judging that the test paper and the test paper are not abnormal, and if the operation method of an operator is abnormal.
4) Comparing the abnormal rates of the blood glucose data of the batch population under the conditions of different equipment models, and judging that the equipment of the model is abnormal if the abnormal rates are higher than a preset threshold value.
In some examples, the start-up quality control module is used for judging whether the use and the storage of the blood glucose test paper meet the requirements according to the blood glucose test paper access data, so as to judge whether the blood glucose test paper works normally.
In some examples, after detecting blood glucose data of a lot of people, the blood glucose standardization measurement system of the embodiment is uploaded to a cloud server in time for storage, so that when people carry out blood glucose measurement next time or carry out related consultation, historical measurement data can be called, and a function of traceable data query is realized.
From the above, it can be seen that the blood glucose standardization measurement system suitable for large-batch crowd provided in this embodiment performs startup quality control before formally performing large-batch measurement, so as to greatly improve detection quality and realize standardization and accuracy of blood glucose measurement. In addition, the reverse inspection of the measuring instrument is performed on the basis of the crowd detection data in batches, which is an inspection function which cannot be realized by a small amount of data, and the detection quality is reversely improved.
It should be understood that the division of the modules of the above apparatus is merely a division of a logic function, and may be fully or partially integrated into a physical entity or may be physically separated when actually implemented. And these modules may all be implemented in software in the form of calls by the processing element; or can be realized in hardware; the method can also be realized in a form of calling software by a processing element, and the method can be realized in a form of hardware by a part of modules. For example, the blood glucose data acquisition module may be a processing element that is set up separately, may be implemented in a chip of the system, or may be stored in a memory of the system in the form of program codes, and the functions of the blood glucose data acquisition module may be called and executed by a processing element of the system. The implementation of the other modules is similar. In addition, all or part of the modules can be integrated together or can be independently implemented. The processing element described herein may be an integrated circuit having signal processing capabilities. In implementation, each step of the above method or each module above may be implemented by an integrated logic circuit of hardware in a processor element or an instruction in a software form.
For example, the modules above may be one or more integrated circuits configured to implement the methods above, such as: one or more Application SPECIFIC INTEGRATED Circuits (ASIC), or one or more microprocessors (DIGITAL SIGNAL processor, DSP), or one or more field programmable gate arrays (Field Programmable GATE ARRAY, FPGA), etc. For another example, when a module above is implemented in the form of a processing element scheduler code, the processing element may be a general-purpose processor, such as a central processing unit (Central Processing Unit, CPU) or other processor that may invoke the program code. For another example, the modules may be integrated together and implemented in the form of a system-on-a-chip (SOC).
Fig. 2 is a schematic flow chart of a blood glucose standardization method suitable for a large population according to an embodiment of the invention. The blood glucose standardization measuring method suitable for large-scale crowd in the embodiment mainly comprises steps S21-S23.
Step S21: and performing quality control after starting.
Step S22: and collecting blood sugar data of a batch of people after the startup quality control is completed.
Step S23: and reversely checking whether the glucometer and the blood glucose test paper work normally or not according to the abnormal rate of blood glucose data of the batch of people.
In some examples, the performing quality control after power-on includes: after starting up, detecting blood sugar of a standard sample; if the blood glucose detection value of the standard sample accords with the theoretical value, determining that the blood glucose data acquisition module accords with the quality control requirement; and if the blood sugar detection value does not accord with the theoretical value, debugging the blood sugar data acquisition module until the blood sugar detection value of the standard sample accords with the theoretical value.
In some examples, the reversely checking whether the blood glucose detector, the blood glucose test paper and the blood glucose measuring staff operate normally according to the abnormal rate of the blood glucose data of the batch crowd comprises: and reversely checking whether the blood glucose detector, the blood glucose test paper and blood glucose measuring staff operate normally or not according to the deviation degree of blood glucose data of the batch population.
It should be noted that, the blood glucose standardization measuring method suitable for large-batch crowd provided by the embodiment can be applied to a blood glucose detecting device with a control chip, not only is used for collecting blood glucose data of the batch crowd, but also the control chip is used for performing quality control after starting up, and according to the abnormal rate of the blood glucose data of the batch crowd, whether the blood glucose detector, the blood glucose test paper and the blood glucose measuring personnel operate normally or not is checked in a reverse mode. The control chip includes, but is not limited to, ARM (Advanced RISC Machines) control chip, FPGA (Field Programmable GATE ARRAY) control chip, soC (System on Chip) control chip, DSP (DIGITAL SIGNAL Processing) control chip, MCU (Micorcontroller Unit) control chip, or the like.
As shown in fig. 3, a schematic structural diagram of an electronic terminal according to an embodiment of the present application is shown. The embodiment of the application provides a structure schematic diagram of another electronic terminal. The electronic terminal provided in this example includes: a processor 31, a memory 32, a communicator 33; the memory 32 is connected to the processor 31 and the communicator 33 via a system bus and performs the communication with each other, the memory 32 is used for storing a computer program, the communicator 33 is used for communicating with other devices, the processor 31 is used for running the computer program, and the electronic terminal is caused to perform the steps of the standardized blood glucose measuring method applicable to a large number of people as above.
The system bus mentioned above may be a peripheral component interconnect standard (PERIPHERAL COMPONENT INTERCONNECT, PCI) bus or an extended industry standard architecture (Extended Industry Standard Architecture, EISA) bus, or the like. The system bus may be classified into an address bus, a data bus, a control bus, and the like. For ease of illustration, the figures are shown with only one bold line, but not with only one bus or one type of bus. The communication interface is used to enable communication between the database access apparatus and other devices (e.g., clients, read-write libraries, and read-only libraries). The memory may include random access memory (Random Access Memory, RAM) and may also include non-volatile memory (non-volatile memory), such as at least one disk memory.
The processor may be a general-purpose processor, including a central processing unit (Central Processing Unit, abbreviated as CPU), a network processor (Network Processor, abbreviated as NP), etc.; but may also be a digital signal processor (DIGITAL SIGNAL Processing, DSP), application Specific Integrated Circuit (ASIC), field-Programmable gate array (FPGA) or other Programmable logic device, discrete gate or transistor logic device, discrete hardware components.
The invention also provides a computer readable storage medium having stored thereon a computer program which when executed by a processor implements the standardized measurement method of blood glucose for a large population of people.
Those of ordinary skill in the art will appreciate that: in the embodiments provided herein, the computer-readable storage medium may include read-only memory, random-access memory, EEPROM, CD-ROM or other optical disk storage, magnetic disk storage or other magnetic storage devices, flash memory, U-disk, removable hard disk, or any other medium that can be used to store desired program code in the form of instructions or data structures and that can be accessed by a computer. In addition, any connection is properly termed a computer-readable medium. For example, if the instructions are transmitted from a website, server, or other remote source using a coaxial cable, fiber optic cable, twisted pair, digital Subscriber Line (DSL), or wireless technologies such as infrared, radio, and microwave, then the coaxial cable, fiber optic cable, twisted pair, DSL, or wireless technologies such as infrared, radio, and microwave are included in the definition of medium. It should be understood, however, that computer-readable and data storage media do not include connections, carrier waves, signals, or other transitory media, but are intended to be directed to non-transitory, tangible storage media. Disk and disc, as used herein, includes Compact Disc (CD), laser disc, optical disc, digital Versatile Disc (DVD), floppy disk and blu-ray disc where disks usually reproduce data magnetically, while discs reproduce data optically with lasers.
In summary, the application provides the blood glucose standardized measurement system, the blood glucose standardized measurement method, the blood glucose standardized measurement terminal and the blood glucose standardized measurement medium suitable for large-batch people. In addition, the reverse inspection of the measuring instrument and the consumable materials is performed on the basis of the batch crowd detection data, which is an inspection function which cannot be realized by a small amount of data, and the detection quality is reversely pushed. Therefore, the application effectively overcomes various defects in the prior art and has high industrial utilization value.
The above embodiments are merely illustrative of the principles of the present application and its effectiveness, and are not intended to limit the application. Modifications and variations may be made to the above-described embodiments by those skilled in the art without departing from the spirit and scope of the application. Accordingly, it is intended that all equivalent modifications and variations of the application be covered by the claims, which are within the ordinary skill of the art, be within the spirit and scope of the present disclosure.
Claims (9)
1. A standardized measurement system for blood glucose in a large population, comprising:
The starting-up quality control module is used for controlling the quality after starting up;
the blood glucose data acquisition module is used for acquiring blood glucose data of a batch of people by utilizing the blood glucose meter after the startup quality control module finishes startup quality control;
The reverse checking module is used for reversely checking whether the blood sugar data acquisition module works normally according to the abnormal rate of blood sugar data of the batch crowd, and at least comprises reversely checking whether the blood sugar tester, the blood sugar test paper and blood sugar measuring staff operate normally;
The reverse checking module checks whether the blood glucose data acquisition module works normally or not, which comprises: comparing abnormal rates of blood glucose data of batch groups under the conditions of the same operator, the same measuring equipment and test papers of different batches; if the abnormality rate is higher than a preset threshold value, judging that the blood glucose test paper is abnormal; comparing abnormal rates of blood glucose data of batches of people under the conditions of the same operator, the same batch of paper strips and different measuring equipment; if the abnormality rate is higher than a preset threshold value, judging that the measuring equipment is abnormal; comparing abnormal rates of blood glucose data of the batch of people under the conditions of the same batch of paper strips, the same measuring equipment and different operators; if the abnormality rate is higher than a preset threshold value, judging that the blood glucose measuring personnel is abnormal in operation; comparing abnormal rates of blood glucose data of the batch population under the condition of different equipment models; if the abnormality rate is higher than a preset threshold value, judging that the equipment of the model is abnormal.
2. The standardized blood glucose measurement system of claim 1 wherein the boot quality control module performs blood glucose measurement on a standard sample after boot; if the blood glucose detection value of the standard sample accords with the theoretical value, determining that the blood glucose data acquisition module accords with the quality control requirement; and if the blood sugar detection value does not accord with the theoretical value, debugging the blood sugar data acquisition module until the blood sugar detection value of the standard sample accords with the theoretical value.
3. The standardized blood glucose measurement system of claim 1 wherein the reverse test module reverse tests whether the blood glucose data collection module is normal based on a degree of deviation of blood glucose data of the population of the lot, the reverse test term comprising at least testing whether blood glucose values are in a biased distribution.
4. The standardized blood glucose measuring system of claim 1 wherein the power-on quality control module is configured to determine whether the blood glucose test strip is used and stored according to the blood glucose test strip access data, so as to determine whether the blood glucose test strip works normally.
5. The standardized blood glucose measurement method suitable for a large number of people is characterized by comprising the following steps:
Performing quality control after starting up;
Collecting blood sugar data of a batch of people after the startup quality control is completed;
according to the abnormal rate of blood sugar data of the batch crowd, reversely checking whether the blood sugar detector, the blood sugar test paper and blood sugar measuring staff operate normally or not;
Wherein, the mode of reverse check blood glucose meter, blood glucose test paper and blood glucose measurement personnel operation whether work normally includes: comparing abnormal rates of blood glucose data of batch groups under the conditions of the same operator, the same measuring equipment and test papers of different batches; if the abnormality rate is higher than a preset threshold value, judging that the blood glucose test paper is abnormal; comparing abnormal rates of blood glucose data of batches of people under the conditions of the same operator, the same batch of paper strips and different measuring equipment; if the abnormality rate is higher than a preset threshold value, judging that the measuring equipment is abnormal; comparing abnormal rates of blood glucose data of the batch of people under the conditions of the same batch of paper strips, the same measuring equipment and different operators; if the abnormality rate is higher than a preset threshold value, judging that the blood glucose measuring personnel is abnormal in operation; comparing abnormal rates of blood glucose data of the batch population under the condition of different equipment models; if the abnormality rate is higher than a preset threshold value, judging that the equipment of the model is abnormal.
6. The standardized measurement method of blood glucose of claim 5, wherein the performing quality control after power-on comprises:
After starting up, detecting blood sugar of a standard sample; if the blood glucose detection value of the standard sample accords with the theoretical value, determining that the blood glucose data acquisition module accords with the quality control requirement; and if the blood sugar detection value does not accord with the theoretical value, debugging the blood sugar data acquisition module until the blood sugar detection value of the standard sample accords with the theoretical value.
7. The standardized blood glucose measuring method of claim 5, wherein the reversely checking whether the blood glucose meter, the blood glucose test paper and the blood glucose measuring person operate normally according to the abnormal rate of the blood glucose data of the population lot comprises: and reversely checking whether the blood glucose detector, the blood glucose test paper and blood glucose measuring staff operate normally or not according to the deviation degree of blood glucose data of the batch population.
8. A computer readable storage medium, on which a computer program is stored, characterized in that the computer program, when executed by a processor, implements the standardized measurement method for blood glucose of any of claims 5 to 7 for a large population.
9. An electronic terminal, comprising: a processor and a memory;
The memory is used for storing a computer program;
The processor is configured to execute the computer program stored in the memory, so that the terminal performs the standardized measurement method for blood glucose for a large population according to any one of claims 5 to 7.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110013925.XA CN112834752B (en) | 2021-01-05 | 2021-01-05 | Blood glucose standardized measurement system, method, terminal and medium suitable for large-scale crowd |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110013925.XA CN112834752B (en) | 2021-01-05 | 2021-01-05 | Blood glucose standardized measurement system, method, terminal and medium suitable for large-scale crowd |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112834752A CN112834752A (en) | 2021-05-25 |
| CN112834752B true CN112834752B (en) | 2024-04-30 |
Family
ID=75926292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110013925.XA Active CN112834752B (en) | 2021-01-05 | 2021-01-05 | Blood glucose standardized measurement system, method, terminal and medium suitable for large-scale crowd |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112834752B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116990532B (en) * | 2023-09-25 | 2023-12-05 | 北京华益精点生物技术有限公司 | Quality control method and related equipment |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101067833A (en) * | 2007-05-09 | 2007-11-07 | 冯连元 | Method for unified standardizing various examination and test results normal range referencel value and its actual measured value in clinical medicine |
| CN101872182A (en) * | 2010-05-21 | 2010-10-27 | 杭州电子科技大学 | A Batch Process Monitoring Method Based on Recursive Nonlinear Partial Least Squares |
| CN106535760A (en) * | 2014-06-16 | 2017-03-22 | 迪亚蒙泰克有限公司 | Non-invasive substance analysis |
| JP2018025517A (en) * | 2016-08-12 | 2018-02-15 | セイコーエプソン株式会社 | Information output system, information output method, and information output program |
| CN108196058A (en) * | 2018-01-02 | 2018-06-22 | 深圳市双平泰医疗科技有限公司 | Blood glucose meter Quality Control detection method and system |
| CN110007087A (en) * | 2019-04-12 | 2019-07-12 | 三诺生物传感股份有限公司 | A kind of measurement blood glucose method based on chargeable blood glucose meter |
| CN110097962A (en) * | 2019-05-07 | 2019-08-06 | 北京医院 | Glycosylated hemoglobin detection and evaluation criterion system |
| CN110124150A (en) * | 2019-04-30 | 2019-08-16 | 广东食品药品职业学院 | It is a kind of based on adaptive softening because of the generalized predictive control closed-loop insulin infusion system of substrategy |
| CN110689954A (en) * | 2019-10-10 | 2020-01-14 | 王月娥 | Multifunctional endocrine detector control system and control method |
| CN110927654A (en) * | 2019-08-23 | 2020-03-27 | 国网天津市电力公司电力科学研究院 | A method for evaluating the batch operation status of smart energy meters |
| CN111307889A (en) * | 2020-04-14 | 2020-06-19 | 漳州卫生职业学院 | A high-precision blood sugar detection device |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5270501B2 (en) * | 2009-09-17 | 2013-08-21 | テルモ株式会社 | Blood glucose meter and blood glucose level measuring method |
-
2021
- 2021-01-05 CN CN202110013925.XA patent/CN112834752B/en active Active
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101067833A (en) * | 2007-05-09 | 2007-11-07 | 冯连元 | Method for unified standardizing various examination and test results normal range referencel value and its actual measured value in clinical medicine |
| CN101872182A (en) * | 2010-05-21 | 2010-10-27 | 杭州电子科技大学 | A Batch Process Monitoring Method Based on Recursive Nonlinear Partial Least Squares |
| CN106535760A (en) * | 2014-06-16 | 2017-03-22 | 迪亚蒙泰克有限公司 | Non-invasive substance analysis |
| JP2018025517A (en) * | 2016-08-12 | 2018-02-15 | セイコーエプソン株式会社 | Information output system, information output method, and information output program |
| CN108196058A (en) * | 2018-01-02 | 2018-06-22 | 深圳市双平泰医疗科技有限公司 | Blood glucose meter Quality Control detection method and system |
| CN110007087A (en) * | 2019-04-12 | 2019-07-12 | 三诺生物传感股份有限公司 | A kind of measurement blood glucose method based on chargeable blood glucose meter |
| CN110124150A (en) * | 2019-04-30 | 2019-08-16 | 广东食品药品职业学院 | It is a kind of based on adaptive softening because of the generalized predictive control closed-loop insulin infusion system of substrategy |
| CN110097962A (en) * | 2019-05-07 | 2019-08-06 | 北京医院 | Glycosylated hemoglobin detection and evaluation criterion system |
| CN110927654A (en) * | 2019-08-23 | 2020-03-27 | 国网天津市电力公司电力科学研究院 | A method for evaluating the batch operation status of smart energy meters |
| CN110689954A (en) * | 2019-10-10 | 2020-01-14 | 王月娥 | Multifunctional endocrine detector control system and control method |
| CN111307889A (en) * | 2020-04-14 | 2020-06-19 | 漳州卫生职业学院 | A high-precision blood sugar detection device |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112834752A (en) | 2021-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108683562B (en) | Anomaly detection positioning method and device, computer equipment and storage medium | |
| CN112834752B (en) | Blood glucose standardized measurement system, method, terminal and medium suitable for large-scale crowd | |
| CN117630800A (en) | Fault diagnosis method and system for automatic calibrating device of electric energy meter | |
| CN109872813A (en) | Detection system positive rate evaluation method and device, computer readable storage medium | |
| JP6060209B2 (en) | System and method for obtaining statistically effective analytical mean and analytical range of quality control substances | |
| CN115268988A (en) | Blood coagulation item detection method and device | |
| CN103336739B (en) | Method for testing software and platform | |
| CN115147236A (en) | Processing method, processing device and electronic equipment | |
| CN113921128B (en) | Automatic medical detection data software auditing method and electronic equipment | |
| CN103743878A (en) | Water quality monitoring data processing method and device | |
| CN117873007B (en) | Manufacturing flow management method, system, equipment and medium based on industrial Internet of things | |
| Westgard et al. | Intelligent Quality Management 2 with IntraSpect™ technology for quality control of GEM® Premier™ 5000 blood gas analyzers—A novel application of the patient sample as its own control | |
| CN118012702A (en) | Temperature monitoring method and device | |
| CN111488272A (en) | Automatic testing method and device for complex transaction files | |
| CN114117831A (en) | Method and device for analyzing data of meter with measuring value in intelligent laboratory | |
| CN116183010B (en) | Fault diagnosis method, device and equipment for dynamic weighing sensor and storage medium | |
| CN112762976B (en) | Automatic method and device for comprehensive test of BMC (baseboard management controller) sensor | |
| CN111128360B (en) | Method, device and system for automatic calibration of medical equipment inspection parameters | |
| CN106607921B (en) | Robot tail end position obtaining method | |
| TWI639143B (en) | Instant clinical biochemical test quality control process | |
| CN118169411A (en) | Quality control out-of-control processing method and device for biochemical analyzer and electronic equipment | |
| CN115934791A (en) | Data inspection method and device | |
| CN116955322A (en) | Performance comparison method and device for stored program, electronic equipment and storage medium | |
| CN116364298A (en) | Reaction curve correction method, sample analyzer and storage medium | |
| CN118824499A (en) | A blood glucose meter automatic test and calibration device and calibration method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |